A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9422-7. doi: 10.1073/pnas.94.17.9422.

Abstract

Neuronal plasticity plays a very important role in brain adaptations to environmental stimuli, disease, and aging processes. The kainic acid model of temporal lobe epilepsy was used to study the long-term anatomical and biochemical changes in the hippocampus after seizures. Using Northern blot analysis, immunocytochemistry, and Western blot analysis, we have found a long-term elevation of the proconvulsive opioid peptide, enkephalin, in the rat hippocampus. We have also demonstrated that an activator protein-1 transcription factor, the 35-kDa fos-related antigen, can be induced and elevated for at least 1 year after kainate treatment. This study demonstrated that a single systemic injection of kainate produces almost permanent increases in the enkephalin and an activator protein-1 transcription factor, the 35-kDa fos-related antigen, in the rat hippocampus, and it is likely that these two events are closely associated with the molecular mechanisms of induction of long-lasting enhanced seizure susceptibility in the kainate-induced seizure model. The long-term expression of the proenkephalin mRNA and its peptides in the kainate-treated rat hippocampus also suggests an important role in the recurrent seizures of temporal lobe epilepsy.

MeSH terms

  • Animals
  • Enkephalins / metabolism*
  • Excitatory Amino Acid Agonists / pharmacology*
  • Hippocampus / metabolism*
  • Kainic Acid / pharmacology*
  • Male
  • Rats
  • Rats, Inbred F344
  • Time Factors
  • Transcription Factor AP-1 / metabolism*

Substances

  • Enkephalins
  • Excitatory Amino Acid Agonists
  • Transcription Factor AP-1
  • Kainic Acid